Global Rapid Diagnostic Leader SD. 2 HIV-2 positive HIV-1 positive 1 drop of blood (Simple) Wait in 1~5 Min. (Fast) Interpret the result visually (Accurate)

Slides:



Advertisements
Similar presentations
Chagas Tests: Development and Standardization
Advertisements

Nick Curry, MD, MPH Infectious Diseases Prevention Section
Unit 6 Diagnosis & Follow-up of HIV Infection
HIV-1/HIV-2 PLUS O To detect HIV Antibody Groups M & O Genetic Systems™ HIV-1/HIV-2 PLUS O EIA   HIV Subtypes and Variants   Description of HIV-1/HIV-2.
Performance of Bio-Rad Genetic Systems HIV-1/HIV-2 Plus O EIA Followed by Multispot or OraQuick Advance in a Dual Immunoassay HIV Testing Strategy Laura.
Utilizing a Non-Commercial Real- Time PCR to Detect HIV-1 RNA in HIV Antibody Negative Diagnostic Sera Submitted to The Maryland Public Health Laboratory.
Results of a Pilot Point-of-Care (POC) HIV Testing Program using INSTI HIV in an Urban Sexual Health Clinic in Canada Presentation to: 2007 HIV Diagnostics.
To evaluate sensitivity, each of the 76 specimens (38 serum pairs) were tested using three serology tests. All testing was performed at the university.
Comparison of the HIV LIA vs WB on HIV-Negative Samples CDC-HIV Diagnostics Meeting “New Diagnostic Technologies” Dec 5-7, 2007 Dr. John Kim National Laboratory.
Comparing the New EIAs with Old Standbys: Florida Bureau of Laboratories Verification Data HIV Diagnostics: New Developments and Challenges Feb. 28, 2005.
Blood Products Advisory Committee Meeting Harold S. Gaithersburg, MD December 14, 2010 Harold S. Margolis, MD Chief, Dengue Branch Centers for Disease.
A Simple and Inexpensive Particle Agglutination Assay for Identifying Recent HIV Infection Niel Constantine 1, Li Hong 2, Kristen Kreisel 1, Anne Sill.
Welcome to Journal club Dr. Md. Abul Hossain Khan Honorary Trainee Department of microbiology, MMC A Comparative Study of Typhidot and Widal Test in Patients.
Vironostika® HIV-1 Plus O Microelisa System
Diagnosis of HIV Infection
Alere TM HIV Combo Yuko Tamanoue, Product Development Department.
Comparison of the Diagnostic Value of the Standard Tube Agglutination Test and the ELISA IgG and IgM in Patients with Brucellosis Presented by Dr. Md.
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Virus Disease Diagnosis Catalino S. Demetria, DVM.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
OnSite HAV IgM Rapid Test Upgraded to Revision H for Better Sensitivity CTK-MK-PPT-R0090 Rev 1.0.
OnSite Toxo IgG/IgM Rapid Test Providing the Full Spectrum of Infection with Toxoplasma.
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al Jouf University.
HIV Testing CDC power point edited by M. Myers
OnSite Rubella IgG/IgM Rapid Test Novel Unique & Only Semi-Quantitative 4-Line Rapid Test.
Laboratory Investigation
HIV Testing Quality Assurance and Quality Control
OnSite Leishmania Ab Rapid Test (Strip) Leishmania IgG / IgM Rapid Test A Leading Product On Market by Using CTK Licensed Patented Antigen.
HIV/AIDS is preventable and treatable, but is incurable.
Transmissibility of B19 by transfusion: evaluation of donor viremia prior to performing a linked donor-recipient study M Busch, representing REDS-II Parvo.
Mycoplasma pneumoniae is not an important cause of lower respiratory tract infections in the European GRACE study: a combination of methods is necessary.
DIAGNOSIS OF HIV INFECTION THE LABORATORY BY DR. K.BUJJIBABU.MD.
Comparison of the diagnostic value of STA test and ELISA IgG and IgM in patients with Brucellosis Mustafa Ertek, Halil Yzgi, Zulal Ozkart et al. Turk.
ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES XVIII International AIDS Conference, July , Vienna Austria Recent Trends in estimated HIV-1.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Panbio Dengue ELISAs.
HIV diagnosis (general) ImmunoassaysNAT (PCR)
Comparison of the diagnostic value of STA test and ELISA IgG and IgM in patients with Brucellosis Mustafa Ertek, Halil Yzgi, Zulal Ozkart et al. Turk J.
Trinity Biotech Fingerstick whole blood sample for HIV OTC test Presented by; Fiona Campbell.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Avidity determination of IgG in diagnosis of tick-born encephalitis Hana Zelená Jiří Januška Jan Raszka Virology department, National Reference Laboratory.
Immunology. Purpose of the immune system: –Discriminate self from non-self Non-self –Antigens Immunity: –All mechanisms used by the host to protect itself.
Panbio Dengue Duo Cassette
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIVAIDS, Viral Hepatitis, STD,
HIV/AIDS is preventable and treatable, but is incurable.
Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity Specificity PPV NPV Performance.
DISCONTINUATION OR NO DISCONTIUNATION: COMPARISON OF SINGLE UNIT HIV ANTIGEN TESTING VS. POOLED NAT TESTING Gerald Schochetman, Ph.D. Abbott Laboratories.
Pantech (Pty) Ltd. SABCOHA Presentation 12 October 2011
IgM ELISA CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY Jan. 1998, p. 7–10 Vol. 5, No. 1 Copyright © 1998, American Society for Microbiology.
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
RETROVIRIDAE GENUS: ONCOVIRUS: HTLV-1 and HTLV-2 SPUMAVIRUS LENTIVIRUS: HIV-1 and HIV-2.
POSTER TEMPLATE BY: om EVALUATION OF A NEW ELISA DIAGNOSTIC KIT FOR CHIKUNGUNYA AND APPLICATION IN AN OUTBREAK SITUATION Caroline.
 Direct  Indirect  Direct: -Microscopy -Culture -Antigen -Nucleic acid  Indirect: -Specific antibody (Serology)
Comparison the laboratory diagnosis of human brucellosis Young Sill Choi*, Young Rok Kim, Sang Hee Park, Soo Kyung Shim, Kyu Jam Hwang and Mi Yeoun Park.
A REVIEW ON HIV DIAGONOSTIC TEST
GENE EXPRESSION STUDY ON PROTEIN LEVEL
Cepheid Symposium IAS 2017 Gwynn Stevens, PhD Director of Virology
TUPEB018 Field evaluation of rapid HIV serologic tests for screening HIV-1/2 infection using serum samples from Rakai Cohort, Uganda. S.C. Kagulire, P.D.
RESULTS AND DISCUSSION
SD Malaria P.f/P.v Antigen Test STANDARD DIAGNOSTICS, INC.
California Clinical Laboratory Association
Laboratory Diagnosis of Infectious Diseases
Rapid Diagnosis of Dengue virus
Do Patients adherent on PrEP exposed to HIV have seroconversion symptoms & falsely reactive HIV tests? Mark Roche1, Elaney Youssef1, Yvonne Gilleece¹,
San Francisco Department of Public Health
مدیریت امور آزمایشگاهها دانشگاه علوم پزشکی کاشان
چرا تست‌های غربالگری مهم هستند
1985: First HIV-1 ELISA Approved by FDA
D. Hvidsten, D.S. Halvorsen, B.P. Berdal, T.J. Gutteberg 
Challenges for Blood Donor Confirmatory Testing Algorithms
Presentation transcript:

Global Rapid Diagnostic Leader SD

2 HIV-2 positive HIV-1 positive 1 drop of blood (Simple) Wait in 1~5 Min. (Fast) Interpret the result visually (Accurate) Rapid Test ? Everybody can detect all of HIV-1 and HIV-2 with only 1 drop of blood in Everywhere, Every time General Information

3 SD BIOLINE HIV-1/2 3.0 Test Immunochromatographic Test for the antibodies of all isotype (IgG, IgM, IgA) specific to HIV-1 including subtype O and HIV-2  The 3rd Generation Method (Direct Sandwich Method, Ag-Ab-Ag)  Serum/Plasma/Whole Blood specimens are avaiable  HIV-1 Subtype “O” Detectable  IgM Detectable : Early HIV1/2 detectable  Sensitivity : 100%  Specificity : 99.8%  Using Capture Antigen : HIV-1 (p24, gp41), HIV-2 (gp36)Ag  Approved by KFDA  Evaluated by WHO  Participation of WHO Tender

4 Quality Data Total numbers of PanelsSD HIV1/2 3.0 Rapid testAbbott Determine Rapid test seroconversion panels tested with SD and compared to Abbott Determine HIV1 Number of missed samples compared to the potential best test  Result : The HIV 1 sensitivity level of SD HIV1/2 Rapid test is superior to Abbott Determine HIV 1. Evaluation 1. Performed by Pasteur Institute France

5 Quality Data I.D Number ---U.S. FDA-Licensed Anti-HIV EIA Test result--- SD BIOLINE HIV1/2 3.0 Abbott HIV-1/2 S/co Gen.Sys HIV S/co Gen.Sys. HIV-1/2 S/co Org.Tek HIV S/co PRB Negative PRB Negative 0.3 (Negative) 0.1 (Negative) 0.1 (Negative) 0.4 (Negative) PRB Positive 1.7 (Positive) 0.1 (Negative) 0.2 (Negative) 0.4 (Negative) PRB Positive 16.6 (Positive) 1.6 (Positive) 1.8 (Positive) 1.8 (Positive) PRB Positive PRB Positive PRB Positive Evaluation 2. Performed by Pasteur Institute with HIV-1 Seroconversion Panel BBI(PRB959) -This evaluation shows the result that SD BIOLINE HIV1/2 3.0 Test can detect antibody for HIV type-1 earlier than some U.S. FDA-Licensed Anti-HIV EIA Kits

6 Quality Data Evaluation 3. Performed by National AIDS RESEARCH INSTITUE in India (1) Panels of sera tested : total 90 sera including 45 confirmed anti-HIV positive and 45 confirmed anti-HIV negative sera by INNO-LIA HIV confirmation(Innogenetics) (2) Evaluation Result - Sensitivity : 100% - Specificity : 100% Evaluation 4. Performed by Christian Medical College and Hospital in India (1) Panels of sera tested : total 100 sera including 25 confirmed anti-HIV positive and 75 confirmed anti-HIV negative sera by PCR (2) Evaluation Result - Sensitivity : 100% - Specificity : 100%

7 Quality Data Evaluation 5. Performed by National AIDS REFERENCE LABORATORY in Malaysia (1)Panels of sera tested : total 100 sera including 50 confirmed anti-HIV type-1 positive and 50 confirmed anti-HIV type-1 negative sera (2)Evaluation Result - Sensitivity : 100% - Specificity : 100%

8 Quality Data Asymptomatic(CDC II)ARC(CDC III)AIDS(CDC IV)Sensitivity SD BIOLINE HIV-1/2 rapid % Behring Anti-HIV1/2 ELISA % A. Evaluation Result with 30 sera of anti-HIV-1 positive Asymptomatic(CDC II)ARC(CDC III)AIDS(CDC IV) Sensitivity SD BIOLINE HIV-1/2 rapid % Behring Anti-HIV1/2 ELISA % PositiveNegativeSpecificity SD BIOLINE HIV-1/2 Rapid % Behring Anti-HIV1/2 ELISA % B. Evaluation Result with 25 sera of anti-HIV-2 positive C. Evaluation Result with 502 sera of anti-HIV-1/2 negative Evaluation 6. Internal evaluation with clinical sera  The result shows that the the accuracy of SD BIOLINE HIV 1/2 is equal to other commercial ELISA kits.

9 Quality Data Evaluation 7. WHO evaluation (phase1) of HIV1/2 Rapid test 1. Result Table Result Sensitivity 100% HIV-1 : 100% HIV-2 : 100% Specificity 99.3% Seroconversion panel : Similar result Behring ELISA SD HIV1/ Reference

10 Quality Data -This evaluation shows the result that SD BIOLINE HIV1/2 3.0 Test can detect antibody for HIV earlier than other commercial HIV1/2 Rapid test kits

11 Quality Data